U.S. Consumer Services Stock News

The United States market has shown robust performance, rising 2.0% over the last week and 23% over the past year, with earnings projected to grow by 19% annually. In such a dynamic environment, identifying small-cap stocks that are potentially undervalued can be an appealing strategy for investors seeking opportunities in various regions.

The United States market has shown robust performance recently, climbing 2.0% in the last seven days and rising 23% over the past year, with earnings forecasted to grow by 19% annually. In this thriving environment, identifying stocks that may be trading below their estimated value can provide opportunities for investors seeking potential growth at a reasonable price.

Over the last 7 days, the United States market has risen by 2.0%, and over the past 12 months, it is up by 23%, with earnings expected to grow significantly in the coming years. For those looking to invest in smaller or newer companies, penny stocks—despite being an older term—can still offer surprising value when they are built on solid financial foundations. In this article, we explore several penny stocks that demonstrate financial strength and potential for long-term growth, offering...

Anyone interested in OneSpan Inc. ( NASDAQ:OSPN ) should probably be aware that the CFO & Treasurer, Jorge A. Martell...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

We wouldn't blame UMB Financial Corporation ( NASDAQ:UMBF ) shareholders if they were a little worried about the fact...

Viewing insider transactions for Equillium, Inc.'s ( NASDAQ:EQ ) over the last year, we see that insiders were net...

Some Argan, Inc. ( NYSE:AGX ) shareholders may be a little concerned to see that the Director, William Griffin...

Insiders who bought US$50.0k worth of Gossamer Bio, Inc. ( NASDAQ:GOSS ) stock in the last year have seen some of their...

Insiders who purchased US$397.5k worth of Alpha Cognition Inc. ( NASDAQ:ACOG ) shares over the past year recouped some...

New Jersey Resources (NJR) drew investor attention after reporting year over year gains in revenue and net profit, along with stronger institutional ownership and supportive technical signals that together highlight a period of reinforced stock momentum. See our latest analysis for New Jersey Resources. At a share price of $55.28, New Jersey Resources has a year to date share price return of 20.23%. Its 1 year total shareholder return of 29.83% and 5 year total shareholder return of 61.60%...

If you are wondering whether Ryman Hospitality Properties stock still offers value at current levels, this article walks through what the numbers are saying about the price you see on screen today. The stock last closed at US$122.35, with returns of 3.1% over 7 days, 12.8% over 30 days, 28.1% year to date, 30.8% over 1 year, 51.1% over 3 years, and 73.6% over 5 years. These figures help frame the context for any discussion of valuation. Recent attention on Ryman Hospitality Properties has...

U.S. economic growth projections near 3%, a healthier labor market, and ongoing investment in infrastructure and technology are reshaping where risk and opportunity sit for industrial-focused stocks. The U.S. Industrial Renaissance screener looks for larger companies tied to manufacturing and infrastructure that may be sensitive to these trends, whether through capital spending, construction activity, or automation and AI buildouts. This article highlights 3 stocks from that screener that...

Fresh commentary on Immatics (NasdaqCM:IMTX) highlights its evolution into a broader PRAME-focused oncology platform with multiple monetization paths, alongside reassurance that existing cash resources are expected to support operations into 2028. See our latest analysis for Immatics. Immatics shares recently traded at US$9.52, with a 1-day share price return of 4.73% and 7-day share price return of 7.33%. Over longer periods, the 30-day share price return is down 10.36% and the year-to-date...

In June 2026, Vir Biotechnology’s Board expanded from seven to eight members and appointed Timothy Coughlin, CPA, as a Class III director and Chair of the Audit Committee, effective June 9, 2026. Coughlin’s audit leadership experience and history guiding biotech companies through regulatory and commercial inflection points could influence how investors view Vir’s governance and execution capabilities. We’ll now examine how adding an experienced audit committee chair like Coughlin may shape...

VisionWave Holdings (VWAV) is in focus after using Eurosatory 2026 in Paris to publicly show its VARAN autonomous unmanned ground vehicle, STRATUM AI management platform, and SDNN AI architecture to the global defense community. See our latest analysis for VisionWave Holdings. Alongside the Eurosatory reveal and new data center joint venture term sheet, VisionWave Holdings has seen short term momentum pick up, with a 7 day share price return of 16.06% and a 30 day return of 9.47%. However,...

Recent defense milestones underscore Virtuix's expanding presence in AI-enabled military training and simulation.

The Fed’s latest meeting left rates steady at 3.5% to 3.75%, but a hint of a possible hike later this year, firmer inflation at 4.2%, and a push toward new data sources have quickly reshaped how investors think about risk and opportunity. For technology and data analytics stocks, the focus on real time information and alternative datasets could matter as much as the rate path itself. This article highlights 3 stocks from a US Technology and Data Analytics Providers screener that appear...

Ryerson Holding (RYZ) has drawn fresh attention after recent trading, with the stock moving from short term pressure to gains over the past month and the past 3 months, prompting a closer look at fundamentals. See our latest analysis for Ryerson Holding. At a share price of $28.04, Ryerson Holding has pulled back slightly in the past week after strong recent momentum, with a 30 day share price return of 13.89% and a 1 year total shareholder return of 40.55% contrasting with a weaker 3 year...

Bristol Myers Squibb (NYSE:BMY) reported positive late-stage clinical trial results for two multiple myeloma candidates. The company announced successful Phase III data for mezigdomide in combination with Kyprolis and dexamethasone. Early data for its CAR T-cell therapy arlocabtagene autoleucel showed a strong response rate with a manageable safety profile. The results were presented at the European Hematology Association Congress 2026. Bristol Myers Squibb is a global biopharmaceutical...

Earlier this month, Dolby Laboratories and NBCUniversal announced that Peacock streamed Telemundo’s live Spanish-language coverage of all 104 FIFA World Cup 2026 matches in Dolby Vision and Dolby Atmos using Dolby AC-4, marking the first commercial use of this codec by a video streamer. Beyond enhancing picture and sound, this rollout positions Dolby’s AC-4 and immersive formats at the core of a high-profile global sports event, reinforcing its role as a go-to technology partner for...

How Ladder Capital Stock Has Been Performing Recently Ladder Capital (LADR) has drawn investor attention after a mixed run in its share price, with the stock down over the year to date but showing gains over the past 3 months and year. This performance sits against reported revenue of $216.26 million and net income of $55.012 million, figures that help frame how the market is currently pricing this US$1.31b real estate investment trust. See our latest analysis for Ladder Capital. The latest...

Coach, part of Tapestry (NYSE:TPR), has launched &Coach, a digital luxury content platform co-created with Gen Z. The platform focuses on social first storytelling and participatory campaigns, with younger creators embedded in the process. &Coach is intended to reshape how the Coach brand builds community and relevance with younger luxury consumers. Tapestry, trading at $145.87, sits behind Coach as its flagship brand and is leaning into a content driven approach to connect with younger...

Tariffs, shifting trade rules, and pressure on global supply chains are reshaping how investors think about US manufacturing stocks. Instead of relying on smooth cross-border trade, markets are reassessing companies that produce more at home and can better control their costs and inputs. This article looks at three US Domestic Manufacturing screener stocks that are directly exposed to these trade headlines and may react in different ways as policies evolve. Each stock is assessed on its...